Brief: Point Biopharma Says Upon Termination Of Agreement Under Specified Circumstances, Co May Be Required To Pay Lilly A Termination Fee Of About $54 Mln

POINT Biopharma Global

03/10/2023 12:57

Oct 3 (Reuters) - Point Biopharma  PNT.O :
    * POINT BIOPHARMA- UPON TERMINATION OF AGREEMENT UNDER
SPECIFIED
CIRCUMSTANCES, CO MAY BE REQUIRED TO PAY LILLY A TERMINATION FEE
OF ABOUT $54 MILLION

Further company coverage:  PNT.O 

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com;))